Sola Failure Decreases Value of Biogen's (BIIB) Aducanumab - BMO Capital

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 6/23/2026

1. SPCX
2. ABBV
3. SPY
4. META
5. MU
6. NVDA
7. BLZE
8. IBM
9. PRIM
10. ACN

Go back to Sola Failure Decreases Value of Biogen's (BIIB) Aducanumab - BMO Capital
BIOGEN IDEC Inc. (NASDAQ: BIIB) Delayed: 197.82 -1.89 (0.95%)
Previous Close $199.71    52 Week High $333.65 
Open $198.88    52 Week Low $223.02 
Day High $201.22    P/E 25.33 
Day Low $197.74    EPS $7.81 
Volume 453,023